CytoDyn (OTCMKTS:CYDY) was upgraded by Zacks Inves
Post# of 148341
(Total Views: 864)
Posted On: 04/10/2020 8:45:04 AM
CytoDyn (OTCMKTS:CYDY) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report issued on Wednesday, Zacks.com reports. The brokerage presently has a $3.25 target price on the biotechnology company’s stock.
https://www.tickerreport.com/banking-finance/...earch.html
https://www.tickerreport.com/banking-finance/...earch.html
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼